EP04.01-022 Real-world Evidence of Durvalumab for Stage III NSCLC: Survival Outcomes and Patterns of Care Post-progression

Autor: P. Aguiar, P. Martins de Marchi, T. Caldas Montella, I. Favato Barcelos, G. Monte Tenório Taveira, R. Duarte Paes, R. Dienstmann, C.G. Moreira Ferreira
Rok vydání: 2022
Předmět:
Zdroj: Journal of Thoracic Oncology. 17:S255
ISSN: 1556-0864
DOI: 10.1016/j.jtho.2022.07.433
Databáze: OpenAIRE